According to GuruFocus Insider Data, these are the largest CEO buys during the past week.
NGL Energy Partners CEO bought 20,000 shares
NGL Energy Partners LP (NGL, Financial) CEO H. Michael Krimbill bought 20,000 shares on Aug. 31 at a price of $11.65. The price of the stock has decreased by 0.86% since.
NGL Energy Partners purchases propane, butane and other natural gas liquids from refiners, processing plants, producers and other parties, and sells the product to retailers, refiners and other participants in the wholesale markets. The company has a market cap of $1.41 billion. Its shares traded at $11.55 as of Sept. 7.
Net loss for the quarter ended June 30 was $169.3 million compared to a net loss of $63.7 million for the prior-year quarter.
The Brink's Co. CEO bought 2,000 shares
President and CEO of The Brink's Co. (BCO, Financial) Douglas A. Pertz bought 2,000 shares on Sept. 6 at a price of $70.03. The price of the stock has increased by 2.88% since.
The Brink's Co., along with its subsidiaries, provides secure logistics and security solutions including cash-in-transit, ATM replenishment and maintenance, cash management services, including vault outsourcing, money processing and intelligent safe services. The company has a market cap of $3.67 billion. Its shares traded at $72.05 with a price-earnings ratio of as of Sept. 7.
Net loss for the second quarter of 2018 was $107.9 million compared to net income of $14.2 million for the prior-year period.
Executive Vice President and Chief Financial Officer Ronald James Domanico bought 2,000 shares on Sept. 7 at a price of $69.45. The price of the stock has increased by 3.74% since.
Athenex CEO bought 5,000 shares
Athenex Inc. (ATNX, Financial) CEO, Chairman of the Board and 10% Owner Johnson Yiu Nam Lau bought 5,000 shares on Sept. 6 at a price of $15.84. The price of the stock has decreased by 0% since.
Athenex is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company has a market cap of $1.05 billion. Its shares traded at $15.84 as of Sept. 7.
Net loss for the second quarter of 2018 was $36.9 million compared to a net loss of $38.6 million in the same period last year.
Director Jinn Wu bought 5,000 shares on Aug. 20 at a price of $17.2 and 2,500 shares on Sept. 6 at a price of $16.09. The price of the stock has decreased by 1.55% since.
Director Song-yi Zhang sold 25,748 shares on Aug. 23 at a price of $17.28; 53,439 shares on Aug. 27 at a price of $17.11; and 51,029 shares on Aug. 29 at a price of $16.61. The price of the stock has decreased by 4.64% since.
Koppers Holdings CEO bought 2,000 shares
Koppers Holdings Inc. (KOP, Financial) President and CEO of Leroy M. Ball bought 2,000 shares on Sept. 6 at a price of $34.96. The price of the stock has decreased by 1.46% since.
Koppers Holdings functions within the specialty chemicals industry. Its products and services are used in railroad, specialty chemical, utility, rubber and construction industries. The company has a market cap of $729.55 million. Its shares traded at $34.45 with a price-earnings ratio of 32.50 as of Sept. 7.
Net income for the second quarter was $600,000 compared to net income of $19.7 million in the prior year quarter.
Director Albert J. Neupaver bought 5,000 shares on Aug. 14 at a price of $35.88. The price of the stock has decreased by 3.99% since.
Vice President, Utility and Industrial Products R. Michael Johnson bought 25,000 shares on Aug. 14 at a price of $35.36. The price of the stock has decreased by 2.57% since.
Senior Vice President, Railroad Products and Services and Global Carbon Materials and Chemicals James A. Sullivan bought 1,000 shares on Aug. 14 at a price of $35.73. The price of the stock has decreased by 3.58% since.
Vice President, Corporate Strategy and Risk Management Leslie S. Hyde sold 1,126 shares on Aug. 27 at a price of $36.35. The price of the stock has decreased by 5.23% since.
OPKO Health CEO bought 10,000 shares
OPKO Health Inc. (OPK, Financial) CEO, Chairman and 10% Owner Phillip Frost bought 10,000 shares on Sept. 5 at a price of $5.79. The price of the stock has decreased by 20.9% since.
OPKO Health is a diversified health care company that seeks to establish industry-leading positions in large, rapidly growing markets. The company has a market cap of $2.56 billion. Its shares traded at $4.58 as of Sept. 7.
Net loss for the second quarter of 2018 was $6.2 million compared to net loss of $16.9 million for the comparable period of 2017.
Frost bought 10,000 shares on Aug. 17 at a price of $5.54; 15,000 shares on Aug. 24 at a price of $5.70; 5,000 shares on Aug. 28 at a price of $5.80; and 5,000 shares on Aug. 30 at a price of $5.90. The price of the stock has decreased by 22.37% since.
For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned in the article.
